Hoerter Joins Agios As Chief Commercial Officer
This article was originally published in Scrip
Agios, a company focused on cancer and rare genetic metabolic disorders, has appointed Steve Hoerter to the newly created position of chief commercial officer – effective Feb. 16, 2016. Hoerter, who brings more than 20 years’ experience to the company, joins Agios from Clovis Oncology Inc. where he was chief commercial officer. He has also held senior commercial roles at Genentech and Roche.